Literature DB >> 20622980

A technical report on exhaled nitric oxide measurement: asthma monitoring in athletes.

Natalia M Grob1, Daniel Laskowski, Raed A Dweik.   

Abstract

Exhaled NO (FE(NO)) measurements have been utilized as a marker to diagnose asthma as well as a non-invasive tool for monitoring airway inflammation and the response to anti-inflammatory medications. One area where this non-invasive monitoring may be helpful is for asthmatic athletes as they train for competitive events. We hypothesized that in the course of training an asthmatic individual may experience worsening of lung inflammation reflected in FE(NO) levels that may be too subtle to detect by conventional methods like spirometry. Data were collected from an asthmatic patient (n = 1) over the course of endurance training using both the desktop (NIOX) and the portable NO (MINO) analyzers daily for eight weeks. We found that average NO levels measured in the desktop system correlated well with the two portable analyzers (r(2) =0.73, r(2) = 0.74 p < 0.0001); additionally, there was a strong correlation between the two MINO devices (r(2) = 0.88; p < 0.0001). A strong negative relationship existed between the number of miles run and NO, regardless of the device used. FEV(1) and PEF, however, did not change significantly as the miles run increased. Exercise training in asthmatics was associated with a decrease (improvement) in NO levels but no significant change in FEV(1) and PEF. This suggests that exhaled NO levels may be more sensitive to changes in the airway as a result of exercise than traditional pulmonary function testing.

Entities:  

Year:  2008        PMID: 20622980      PMCID: PMC2901124          DOI: 10.1088/1752-7155/2/3/037027

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  20 in total

1.  Pulmonary hypertension and the search for the selective pulmonary vasodilator.

Authors:  Raed A Dweik
Journal:  Lancet       Date:  2002-09-21       Impact factor: 79.321

2.  Exhaled nitric oxide predicts asthma exacerbation.

Authors:  Michelle S Harkins; Karen-Lynn Fiato; Gary K Iwamoto
Journal:  J Asthma       Date:  2004-06       Impact factor: 2.515

3.  Exhaled nitric oxide in asthma. From diagnosis, to monitoring, to screening: are we there yet?

Authors:  Natalia M Grob; Raed A Dweik
Journal:  Chest       Date:  2008-04       Impact factor: 9.410

Review 4.  Mechanisms of asthma in Olympic athletes--practical implications.

Authors:  T Haahtela; P Malmberg; A Moreira
Journal:  Allergy       Date:  2008-06       Impact factor: 13.146

5.  Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes.

Authors:  Jonathan P Parsons; Christopher Kaeding; Gary Phillips; David Jarjoura; Gail Wadley; John G Mastronarde
Journal:  Med Sci Sports Exerc       Date:  2007-09       Impact factor: 5.411

6.  Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.

Authors:  Andrew D Smith; Jan O Cowan; Karen P Brassett; G Peter Herbison; D Robin Taylor
Journal:  N Engl J Med       Date:  2005-05-24       Impact factor: 91.245

7.  Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission.

Authors:  M W Pijnenburg; W Hofhuis; W C Hop; J C De Jongste
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

8.  Changes of exhaled nitric oxide during steroid treatment of childhood asthma.

Authors:  J Beck-Ripp; M Griese; S Arenz; C Köring; B Pasqualoni; P Bufler
Journal:  Eur Respir J       Date:  2002-06       Impact factor: 16.671

9.  Asthma deaths during sports: report of a 7-year experience.

Authors:  Jack M Becker; James Rogers; Gregory Rossini; Haresh Mirchandani; Gilbert E D'Alonzo
Journal:  J Allergy Clin Immunol       Date:  2004-02       Impact factor: 10.793

10.  Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide.

Authors:  D H Yates; S A Kharitonov; R A Robbins; P S Thomas; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.